{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:16:54Z","timestamp":1791173814622,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,9,15]],"date-time":"2006-09-15T00:00:00Z","timestamp":1158278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jrnl Neuroimmune Pharm"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/s11481-006-9039-x","type":"journal-article","created":{"date-parts":[[2006,9,14]],"date-time":"2006-09-14T20:30:44Z","timestamp":1158265844000},"page":"81-86","source":"Crossref","is-referenced-by-count":97,"title":["Strategies for Intranasal Delivery of Therapeutics for the Prevention and Treatment of NeuroAIDS"],"prefix":"10.1007","volume":"2","author":[{"given":"Leah R.","family":"Hanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"William H.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,9,15]]},"reference":[{"key":"9039_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neulet.2003.12.005","volume":"361","author":"RN Alcalay","year":"2004","unstructured":"Alcalay RN, Giladi E, Pick CG, Gozes I (2004) Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze. Neurosci Lett 361:128\u2013131","journal-title":"Neurosci Lett"},{"key":"9039_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1124\/jpet.103.063222","volume":"309","author":"WA Banks","year":"2004","unstructured":"Banks WA, During MJ, Niehoff ML (2004) Brain uptake of the glucagon-like peptide-1 antagonist exendin(9\u201339) after intranasal administration. J Pharmacol Exp Ther 309:469\u2013475","journal-title":"J Pharmacol Exp Ther"},{"key":"9039_CR3","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","volume":"29","author":"C Benedict","year":"2004","unstructured":"Benedict C, Hallschmid M, Hatke A, Schultes B, Fehm HL, Born J, Kern W (2004) Intranasal insulin improves memory in humans. Psychoneuroendocrinology 29:1326\u20131334","journal-title":"Psychoneuroendocrinology"},{"key":"9039_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nn849","volume":"5","author":"J Born","year":"2002","unstructured":"Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL (2002) Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5:514\u2013516","journal-title":"Nat Neurosci"},{"key":"9039_CR5","doi-asserted-by":"publisher","first-page":"12432","DOI":"10.1073\/pnas.192442999","volume":"99","author":"S Capsoni","year":"2002","unstructured":"Capsoni S, Giannotta S, Cattaneo A (2002) Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice. Proc Nat Acad Sci USA 99:12432\u201312437","journal-title":"Proc Nat Acad Sci USA"},{"key":"9039_CR6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-1998-1102","volume":"1","author":"XQ Chen","year":"1998","unstructured":"Chen XQ, Fawcett JR, Rahman YE, Ala TA, Frey WH II (1998) Delivery of nerve growth factor to the brain via the olfactory pathway. J Alzheimer\u2019s Dis 1:35\u201344","journal-title":"J Alzheimer\u2019s Dis"},{"key":"9039_CR7","doi-asserted-by":"crossref","first-page":"S1:2","DOI":"10.1016\/j.surneu.2005.06.030","volume":"65","author":"CO Fonseca da","year":"2006","unstructured":"da Fonseca CO, Landeiro JA, Clark SS, Quirico-Santos T, da Costa Carvalho Mda G, Gattass CR (2006) Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol. Surg Neurol 65 S1:2\u20131:9","journal-title":"Surg Neurol"},{"key":"9039_CR8","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1073\/pnas.0500195102","volume":"102","author":"R Rosa De","year":"2005","unstructured":"De Rosa R, Garcia AA, Braschi C, Capsoni S, Maffei L, Berardi N, Cattaneo A (2005) Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc Natl Acad Sci USA 102:3811\u20133816","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9039_CR9","first-page":"64","volume":"5","author":"DS Dhanda","year":"2005","unstructured":"Dhanda DS, Frey WH 2nd, Leopold D, Kompella UB (2005) Approaches for drug deposition in the human olfactory epithelium. Drug Deliv Technol 5:64\u201372","journal-title":"Drug Deliv Technol"},{"key":"9039_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/BF03033447","volume":"6","author":"H Dou","year":"2004","unstructured":"Dou H, Kingsley JD, Mosley RL, Gelbard HA, Gendelman HE (2004) Neuroprotective strategies for HIV-1 associated dementia. Neurotox Res 6:503\u2013521","journal-title":"Neurotox Res"},{"key":"9039_CR11","first-page":"418","volume":"2","author":"R Draghia","year":"1995","unstructured":"Draghia R, Caillaud C, Manicom R, Pavirani A, Kahn A, Poenaru L (1995) Gene delivery into the central nervous system by nasal instillation in rats. Gene Ther 2:418\u201323","journal-title":"Gene Ther"},{"key":"9039_CR12","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm919","volume":"9","author":"MJ During","year":"2003","unstructured":"During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, Klugmann M, Banks WA, Drucker DJ, Haile CN (2003) Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nature Med 9:1173\u20131179","journal-title":"Nature Med"},{"key":"9039_CR13","unstructured":"Frey WH 2nd (1991) Neurologic agents for nasal administration the brain. World Intellectual Property Organization. PCT priority date 5.12.89, WO 91\/07947"},{"key":"9039_CR14","unstructured":"Frey WH 2nd (2002) Bypassing the blood\u2013brain barrier to delivery thereapeutic agents to the brain and spinal cord. Drug Deliv Technol (5):46\u201349"},{"key":"9039_CR15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10717549709051878","volume":"4","author":"W.H. Frey 2nd","year":"1997","unstructured":"Frey WH 2nd, Liu, J, Chen, X, Thorne, RG, Fawcett, JR, Ala, TA, Rahman, Y-E (1997) Delivery of 125I-NGF to the brain via the olfactory route. Drug Deliv 4:87\u201392","journal-title":"Drug Deliv"},{"key":"9039_CR16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00126334-200406010-00001","volume":"36","author":"F Gimenez","year":"2004","unstructured":"Gimenez F, Fernandez C, Mabondzo A (2004) Transport of HIV protease inhibitors through the blood\u2013brain barrier and interactions with the efflux proteins, P-glycoprotein and multidrug resistance proteins. J Acquir Immune Defic Syndr 36:649\u201358","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9039_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1749-6632.2000.tb06957.x","volume":"921","author":"I Gozes","year":"2000","unstructured":"Gozes I, Zamostiano R, Pinhasov A, Bassan M, Giladi E, Steingart RA, Brenneman DE (2000) A novel VIP responsive gene. Activity dependent neuroprotective protein. Ann NY Acad Sci 921:115\u2013118","journal-title":"Ann NY Acad Sci"},{"key":"9039_CR18","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1023\/A:1025053115583","volume":"20","author":"CL Graff","year":"2003","unstructured":"Graff CL, Pollack GM (2003) P-glycoprotein attenuates brain uptake of substrates after nasal instillation. Pharm Res 20:1225\u20131230","journal-title":"Pharm Res"},{"key":"9039_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11095-004-9013-3","volume":"22","author":"CL Graff","year":"2005","unstructured":"Graff CL, Pollack GM (2005) Functional evidence for P-glycoprotein at the nose\u2013brain barrier. Pharm Res 22:86\u201393","journal-title":"Pharm Res"},{"key":"9039_CR20","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.2337\/diabetes.53.11.3024","volume":"53","author":"M Hallschmid","year":"2004","unstructured":"Hallschmid M, Benedict C, Schultes B, Fehm HL, Born J, Kern W (2004) Intranasal insulin reduces body fat in men but not in women. Diabetes 53:3024\u20133029","journal-title":"Diabetes"},{"key":"9039_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1210\/jc.2005-0906","volume":"91","author":"M Hallschmid","year":"2006","unstructured":"Hallschmid M, Smolnik R, McGregor G, Born J, Fehm HL (2006) Overweight humans are resistant to the weight-reducing effects of melanocortin4\u201310. J Clin Endocrinol Metab 91:522\u2013525","journal-title":"J Clin Endocrinol Metab"},{"key":"9039_CR22","first-page":"65","volume":"4","author":"LR Hanson","year":"2004","unstructured":"Hanson LR, Martinez PM, Taheri S, Kamsheh L, Mignot E, Frey WH 2nd (2004) Intranasal administration of hypocretin 1 (orexin A) bypasses the blood\u2013brain barrier and targets the brain: a new strategy for the treatment of narcolepsy. Drug Delive Technol 4:65\u201371","journal-title":"Drug Delive Technol"},{"key":"9039_CR23","unstructured":"Hashizume R, Ozawa T, Gryaznov SM, Santos RA, Lamborn KR, Frey WH 2nd, Deen DF (2006) Intranasal delivery of specific telomerase inhibitor GRN163 in human glioblastoma xenografts. American Association of Neurological Surgeons Abstract: 2006 Apr 24"},{"key":"9039_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/archneur.55.1.41","volume":"55","author":"PN Heseltine","year":"1998","unstructured":"Heseltine PN, Goodkin K, Atkinson JH, Vitello B, Rochon J, Heaton RK, Eaton EM, Wilkie FL, Sobel E, Brown SJ, Feaster D, Schneider L, Goldschmidts WL, Stover ES (1998) Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment. Arch Neurol 55:41\u201351","journal-title":"Arch Neurol"},{"key":"9039_CR25","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.ymthe.2003.09.010","volume":"8","author":"A Jerusalmi","year":"2003","unstructured":"Jerusalmi A, Morris-Downes MM, Sheahan BJ, Atkins GJ (2003) Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis. Mol Ther 8:886","journal-title":"Mol Ther"},{"key":"9039_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/ana.10506","volume":"53","author":"K Jin","year":"2003","unstructured":"Jin K, Xie L, Childs J, Sun Y, Mao XO, Logvinova A, Greenberg DA (2003) Cerebral neurogenesis is induced by intranasal administration of growth factors. Ann Neurol 53:405\u2013409","journal-title":"Ann Neurol"},{"key":"9039_CR27","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s11095-005-5420-3","volume":"22","author":"KK Kandimalla","year":"2005","unstructured":"Kandimalla KK, Donovan MD (2005a) Localization and differential activity of P-glycoprotein in the bovine olfactory and nasal respiratory mucosae. Pharm Res 22:1121\u20131128","journal-title":"Pharm Res"},{"key":"9039_CR28","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/jps.20284","volume":"94","author":"KK Kandimalla","year":"2005","unstructured":"Kandimalla KK, Donovan MD (2005b) Carrier mediated transport of chlorpheniramine and chlorcyclizine across bovine olfactory mucosa: implications on nose-to-brain transport. J Pharm Sci 94:613\u2013624","journal-title":"J Pharm Sci"},{"key":"9039_CR29","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1126\/science.3016903","volume":"233","author":"S Koenig","year":"1986","unstructured":"Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS (1986). Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089\u201393","journal-title":"Science"},{"issue":"7042","key":"9039_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nature03701","volume":"435","author":"M Kosfeld","year":"2005","unstructured":"Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E (2005) Oxytocin increases trust in humans. Nature 435(7042):673\u2013676","journal-title":"Nature"},{"issue":"5","key":"9039_CR31","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.ymthe.2005.12.013","volume":"13","author":"JM Laing","year":"2006","unstructured":"Laing JM, Gober MD, Golembewski EK, Thompson SM, Gyure KA, Yarowsky PJ, Aurelian L (2006) Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice. Mol Ther 13(5):870\u2013881","journal-title":"Mol Ther"},{"key":"9039_CR32","doi-asserted-by":"publisher","first-page":"10078","DOI":"10.1128\/JVI.77.18.10078-10087.2003","volume":"77","author":"F Lemiale","year":"2003","unstructured":"Lemiale F, Kong WP, Akyurek LM, Ling X, Huang Y, Chakrabarti BK, Eckhaus M, Nabel GJ (2003) Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system. J Virol 77:10078\u201310087","journal-title":"J Virol"},{"key":"9039_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jstrokecerebrovasdis.2004.01.005","volume":"13","author":"XF Liu","year":"2004","unstructured":"Liu XF, Fawcett JR, Hanson LR, Frey WH 2nd (2004) The window of opportunity for treatment of focal cerebral ischemic damage with noninvasive intranasal insulin-like growth factor-I in rats. J Stroke Cerebrovasc Dis 13:16\u201323","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"9039_CR34","volume-title":"Intranasal deferoxamine protects against subsequent stroke. Program No. 456.15. 2004 Abstract Viewer\/Itinerary Planner","author":"SS Panter","year":"2004","unstructured":"Panter SS, Coppes VG, Ferrell CM, Chavez JC, Ratan RR, Frey WH 2nd (2004) Intranasal deferoxamine protects against subsequent stroke. Program No. 456.15.2004 Abstract Viewer\/Itinerary Planner. Washington, DC: Society for Neuroscience"},{"key":"9039_CR35","unstructured":"Pereira CF, Nottet HLSM (2000) The blood\u2013brain barrier in HIV-associated Dementia. NeuroAids 3(2), online"},{"key":"9039_CR36","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0196-9781(03)00176-1","volume":"24","author":"MT Polianova","year":"2003","unstructured":"Polianova MT, Ruscetti FW, Pert CB, Tractenberg RE, Leoung G, Strang S, Ruff MR (2003) Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA). Peptides 24:1093\u20131098","journal-title":"Peptides"},{"key":"9039_CR37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2004.11.011","volume":"27","author":"RegerMA Watson","year":"2006","unstructured":"Reger MA, Watson GS, Frey WH 2nd, Baker LD, Cholerton B, Keeling ML, Belongia DA, Fishel MA, Plymate SR, Schellenberg GD, Cherrier MM, Craft S (2006) Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging 27:451\u2013458","journal-title":"Neurobiol Aging"},{"key":"9039_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jneuroim.2004.02.011","volume":"151","author":"TM Ross","year":"2004","unstructured":"Ross TM, Martinez PM, Renner JC, Thorne RG, Hanson LR, Frey WH 2nd (2004) Intranasal administration of interferon beta bypasses the blood\u2013brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis. J Neuroimmunol 151:66\u201377","journal-title":"J Neuroimmunol"},{"key":"9039_CR39","doi-asserted-by":"crossref","unstructured":"Ruff MR, Polianova M, Pert CB, Ruscetti FW (2001) Peptide T inhibits HIV-1 infection mediated by the chemokine receptor-5 (CCR5). Antiviral Res 52\u201363","DOI":"10.1016\/S0166-3542(01)00163-2"},{"key":"9039_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1570162033352066","volume":"1","author":"MR Ruff","year":"2003","unstructured":"Ruff MR, Polianova M, Yang QE, Leoung GS, Ruscetti FW, Pert CB (2003) Update on D-ala-peptide T-amide (DAPTA): a viral entry inhibitor that blocks CCR5 chemokine receptors. Curr HIV Res 1:51\u201367","journal-title":"Curr HIV Res"},{"key":"9039_CR41","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1210\/en.2003-1431","volume":"145","author":"C Schulz","year":"2004","unstructured":"Schulz C, Paulus K, Lehnert H (2004) Central nervous and metabolic effects of intranasally applied leptin. Endocrinol 145:2696\u20132701","journal-title":"Endocrinol"},{"key":"9039_CR42","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/sj.ijo.0802951","volume":"29","author":"H Shimizu","year":"2005","unstructured":"Shimizu H, Oh-I S, Okada S, Mori M (2005) Inhibition of appetite by nasal leptin administration in rats. Int J Obes 29:858\u2013863","journal-title":"Int J Obes"},{"key":"9039_CR43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2745\/dds.14.365","volume":"14","author":"T Shingaki","year":"1999","unstructured":"Shingaki T, Sakane T, Yamashita S, Sezaki H, Tokunaga Y, Shibata S (1999) Transnasal delivery of anticancer drugs to the brain tumors: a new strategy for brain tumor chemotherapy. Drug Deliv Syst 14:365\u2013371","journal-title":"Drug Deliv Syst"},{"key":"9039_CR44","doi-asserted-by":"publisher","first-page":"907","DOI":"10.2165\/00003088-200140120-00003","volume":"40","author":"RG Thorne","year":"2001","unstructured":"Thorne, RG, Frey WH 2nd (2001) Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin Pharmacokinet 40:907\u2013946","journal-title":"Clin Pharmacokinet"},{"key":"9039_CR45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","volume":"127","author":"RG Thorne","year":"2004","unstructured":"Thorne RG, Pronk GJ, Padmanabhan V, Frey WH 2nd (2004) Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127:481\u201396","journal-title":"Neuroscience"},{"key":"9039_CR46","first-page":"403","volume":"126","author":"R Vazeux","year":"1987","unstructured":"Vazeux R, Brousse N, Jarry A, Henin D, Marche C, Vedrenne C, Mikol J, Wolff M, Michon C, Rozenbaum W, Bureau JF, Montagnier L, Brahic M (1987). AIDS subacute encephalitis. Identification of HIV-infected cells. Am J Pathol 126:403\u2013410","journal-title":"Am J Pathol"},{"key":"9039_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00280-005-0018-3","volume":"57","author":"D Wang","year":"2005","unstructured":"Wang D, Gao Y, Yun L (2005) Study on brain targeting of raltitrexed following intranasal administration in rats. Cancer Chemother Pharmacol 57:97\u2013104","journal-title":"Cancer Chemother Pharmacol"},{"key":"9039_CR48","first-page":"48","volume":"4","author":"F Wang","year":"2004","unstructured":"Wang F, Jiang XG, Lu W (2004) Intranasal delivery of methotrexate to the brain in rats bypassing the blood\u2013brain barrier. Drug Deliv Technol 4:48\u201355","journal-title":"Drug Deliv Technol"},{"key":"9039_CR49","doi-asserted-by":"publisher","first-page":"7089","DOI":"10.1073\/pnas.83.18.7089","volume":"83","author":"CA Wiley","year":"1986","unstructured":"Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83:7089\u20137093","journal-title":"Proc Natl Acad Sci USA"},{"key":"9039_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neulet.2005.07.008","volume":"387","author":"YP Yu","year":"2005","unstructured":"Yu YP, Xu QQ, Zhang Q, Zhang WP, Zhang LH, Wei EQ (2005) Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia. Neurosci Lett 387:5\u201310","journal-title":"Neurosci Lett"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-006-9039-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-006-9039-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-006-9039-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-006-9039-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T03:00:17Z","timestamp":1581994817000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-006-9039-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,15]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["9039"],"URL":"https:\/\/doi.org\/10.1007\/s11481-006-9039-x","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,15]]}}}